CNBX Pharms (CNBX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 84 223 sessions, September 8, 2025 to September 8, 2026
- Largest daily move
- +200% close of April 20, 2026
- 1-year change
- -80% closing prices, September 8, 2025 to September 8, 2026
Company Description
CNBX Pharms (OTC Link: CNBX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $160.6K.
CNBX has declined 80.0% over the past year. The last closing price was $0.0001.
For FY2025, CNBX Pharms reported revenue of $0 and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for CNBX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CNBX Pharms (CNBX) closed at $0.0001 on September 8, 2026. Over the past 12 months, the price has lost 80.0%.
CNBX Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CNBX Pharms has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial. View all CNBX news →
SEC Filings
CNBX Pharms has filed 5 recent SEC filings, including 2 Form SCHEDULE 13G/A, 2 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNBX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CNBX Pharms (CNBX) currently stands at 1.3 million shares, down 10.4% from the previous reporting period, representing 0.1% of the float. Since September 2025, short interest has increased by 10251.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for CNBX Pharms (CNBX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CNBX Company Profile & Sector Positioning
CNBX Pharms (CNBX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNBX often look at related companies in the same sector, including PaxMedica, Inc. (PXMD), Marizyme (MRZM), Bassline Productions Inc (BSSP), Itoco Inc (ITMC), and Navidea Biopharm (NAVB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNBX's relative position within its industry.